These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2990765)

  • 1. A new family with dexamethasone-suppressible hyperaldosteronism: aldosterone unresponsiveness to angiotensin II.
    Fallo F; Sonino N; Armanini D; Luzzi T; Pedini F; Pasini C; Mantero F
    Clin Endocrinol (Oxf); 1985 Jun; 22(6):777-85. PubMed ID: 2990765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension corrected and aldosterone responsiveness to renin-angiotensin restored by long-term dexamethasone in glucocorticoid-suppressible hyperaldosteronism.
    Woodland E; Tunny TJ; Hamlet SM; Gordon RD
    Clin Exp Pharmacol Physiol; 1985; 12(3):245-8. PubMed ID: 2992855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of naloxone on the pituitary-adrenal axis in patients with dexamethasone-suppressible hyperaldosteronism.
    Fallo F; Boscaro M; Sonino N; Mantero F
    Clin Endocrinol (Oxf); 1987 Feb; 26(2):163-8. PubMed ID: 2822294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone-suppressible hyperaldosteronism. Adrenal transition cell hyperplasia?
    Connell JM; Kenyon CJ; Corrie JE; Fraser R; Watt R; Lever AF
    Hypertension; 1986 Aug; 8(8):669-76. PubMed ID: 3015796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical evidence of aldosterone overproduction and abnormal regulation in normotensive individuals with familial hyperaldosteronism type I.
    Stowasser M; Huggard PR; Rossetti TR; Bachmann AW; Gordon RD
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4031-6. PubMed ID: 10566645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial, dexamethasone-suppressible, normokalemic hyperaldosteronism.
    Grim CE; Weinberger MH
    Pediatrics; 1980 Mar; 65(3):597-604. PubMed ID: 6987607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin-aldosterone response to dexamethasone in glucocorticoid-suppressible hyperaldosteronism is altered by coexistent renal artery stenosis.
    Stowasser M; Gordon RD; Klemm SA; Tunny TJ
    J Clin Endocrinol Metab; 1993 Sep; 77(3):800-4. PubMed ID: 8396580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenal glomerulosa function in patients with dexamethasone-suppressible hyperaldosteronism.
    Oberfield SE; Levine LS; Stoner E; Chow D; Rauh W; Greig F; Lee SM; Lightner E; Witte M; New MI
    J Clin Endocrinol Metab; 1981 Jul; 53(1):158-64. PubMed ID: 7016891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on clinical and endocrine characteristics of dexamethasone-suppressible hyperaldosteronism compared with those in primary aldosteronism owing to aldosterone-producing adenoma.
    Yamakita N; Yasuda K; Noritake N; Mercado-Asis LB; Murase H; Mune T; Morita H; Miura K
    Acta Endocrinol (Copenh); 1989 Sep; 121(3):334-44. PubMed ID: 2552725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term evolution of glucocorticoid-suppressible hyperaldosteronism.
    Stockigt JR; Scoggins BA
    J Clin Endocrinol Metab; 1987 Jan; 64(1):22-6. PubMed ID: 3536983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differing effects of metoclopramide and adrenocorticotropin on plasma aldosterone levels in glucocorticoid-suppressible hyperaldosteronism and other forms of hyperaldosteronism.
    Ganguly A; Pratt JH; Weinberger MH; Grim CE; Fineberg NS
    J Clin Endocrinol Metab; 1983 Aug; 57(2):388-92. PubMed ID: 6306041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of naloxone on the adrenal cortex in primary aldosteronism.
    Fallo F; Boscaro M; Sonino N; Mantero F
    Am J Hypertens; 1988 Jul; 1(3 Pt 1):280-2. PubMed ID: 2839206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism.
    Fallo F; Pilon C; Williams TA; Sonino N; Morra Di Cella S; Veglio F; De Iasio R; Montanari P; Mulatero P
    J Hum Hypertens; 2004 Jan; 18(1):47-51. PubMed ID: 14688810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 10. Hypertension. A comparison of the effects of angiotensin II infusion and variations in salt intake on plasma aldosterone levels in normal subjects, patients with essential hypertension and patients with hyperaldosteronism.
    Zoccali C; Usherwood T; Brown JJ; Lever AF; Robertson JI; Fraser R
    J Steroid Biochem; 1983 Jul; 19(1A):327-31. PubMed ID: 6310234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone suppressible hyperaldosteronism in a child with nephrosclerosis.
    Lee SM; Lightner E; Witte M; Oberfield S; Levine L; New MI
    Acta Endocrinol (Copenh); 1982 Feb; 99(2):251-5. PubMed ID: 6277130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for persistent dysfunction of wild-type aldosterone synthase gene in glucocorticoid-treated familial hyperaldosteronism type I.
    Stowasser M; Taylor WL; Gartside MG; Tunny TJ; Gordon RD
    J Hypertens; 1997 Dec; 15(12 Pt 2):1729-33. PubMed ID: 9488230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bromocriptine treatment on the aldosterone response to angiotensin II and adrenocorticotropin in idiopathic hyperaldosteronism.
    Wisgerhof M; Mellinger RC
    J Clin Endocrinol Metab; 1985 Jul; 61(1):192-5. PubMed ID: 2987293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma-aldosterone and renin activity in Bartter's syndrome (author's transl)].
    Rössler R
    Dtsch Med Wochenschr; 1975 Nov; 100(47):2443-8. PubMed ID: 171132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and pathophysiologic studies of a new kindred with glucocorticoid-suppressible hyperaldosteronism manifest in three generations.
    Ganguly A; Grim CE; Bergstein J; Brown RD; Weinberger MH
    J Clin Endocrinol Metab; 1981 Nov; 53(5):1040-6. PubMed ID: 7026592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normotensive glucocorticoid-suppressible hyperaldosteronism in adult.
    Maeda T; Ashie T; Kikuiri K; Takakura M; Hikita N; Nakagawa H; Shimamoto K
    Endocrinol Jpn; 1989 Dec; 36(6):817-25. PubMed ID: 2633910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.